Abstract
The markets for small joint implants in Europe, Asia-Pacific (AP), and the
Rest-of-the-World (ROW) feature significant regional differences. These
differences, which include demographics, disease prevalence, economic status,
and regulatory and reimbursement challenges, are expected to have a
significant impact on the opportunities for small joint implant suppliers in
markets outside of the U.S.
In Europe, aging populations are contributing to the rising prevalence of
conditions affecting the small joints, which will drive growth in revenues.
Cost-containment efforts and the relative maturity of certain product markets,
however, will influence prices and product purchases. AP and ROW countries
vary with respect to demographics, disease prevalence, and economic status.
Processes for regulatory approval, reimbursement, and distribution channels
have contributed to different levels of maturity for the markets in these
countries.
This report examines the factors influencing revenues for small joint implants
in the shoulder, elbow, wrist, fingers, ankle and foot, with a special focus
on international regions. Procedure and market forecasts are provided through
2015.
| 
View Cart
